Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant

Transthyretin amyloidosis (ATTR) variant is a life-threatening hereditary disease predominantly affecting the peripheral nervous system and heart. Tafamidis, which prevents the deposition of amyloid by stabilizing transthyretin, is available for the treatment of neuropathy and cardiomyopathy of ATTR...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of Medical Investigation 2022, Vol.69(3.4), pp.320-322
Hauptverfasser:	Yagi, Shusuke, Yamazaki, Hiromu, Kusunose, Kenya, Osaki, Yusuke, Ise, Takayuki, Kadota, Muneyuki, Tserensonom, Munkhtsetseg, Kawabata, Yutaka, Hara, Tomoya, Ueno, Rie, Saijo, Yoshihito, Matsuura, Tomomi, Yamaguchi, Koji, Yamada, Hirotsugu, Fukuda, Daiju, Soeki, Takeshi, Wakatsuki, Tetsuzo, Sata, Masataka
Format:	Artikel
Sprache:	eng
Schlagworte:	cardiomyopathy hereditary amyloidosis hypertrophic hepertrophy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!